183 related articles for article (PubMed ID: 30295190)
1. Utilization of Analytical Omics Tools in the Molecular Diagnostics of Multiple Myeloma.
Kovacs Z; Guttman A
Curr Mol Med; 2018; 18(4):260-272. PubMed ID: 30295190
[TBL] [Abstract][Full Text] [Related]
2. The microenvironment and molecular biology of the multiple myeloma tumor.
Lemaire M; Deleu S; De Bruyne E; Van Valckenborgh E; Menu E; Vanderkerken K
Adv Cancer Res; 2011; 110():19-42. PubMed ID: 21704227
[TBL] [Abstract][Full Text] [Related]
3. Biomedical analysis of formalin-fixed, paraffin-embedded tissue samples: The Holy Grail for molecular diagnostics.
Donczo B; Guttman A
J Pharm Biomed Anal; 2018 Jun; 155():125-134. PubMed ID: 29627729
[TBL] [Abstract][Full Text] [Related]
4. From research cohorts to the patient - a role for "omics" in diagnostics and laboratory medicine?
Vogeser M; Bendt AK
Clin Chem Lab Med; 2023 May; 61(6):974-980. PubMed ID: 36592431
[TBL] [Abstract][Full Text] [Related]
5. Cell autonomous and microenvironmental regulation of tumor progression in precursor states of multiple myeloma.
Manier S; Kawano Y; Bianchi G; Roccaro AM; Ghobrial IM
Curr Opin Hematol; 2016 Jul; 23(4):426-33. PubMed ID: 27101529
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs: Novel Crossroads between Myeloma Cells and the Bone Marrow Microenvironment.
Raimondi L; De Luca A; Morelli E; Giavaresi G; Tagliaferri P; Tassone P; Amodio N
Biomed Res Int; 2016; 2016():6504593. PubMed ID: 26881223
[TBL] [Abstract][Full Text] [Related]
7. The potential diagnostic power of extracellular vesicle analysis for multiple myeloma.
Canella A; Harshman SW; Radomska HS; Freitas MA; Pichiorri F
Expert Rev Mol Diagn; 2016; 16(3):277-84. PubMed ID: 26671731
[TBL] [Abstract][Full Text] [Related]
8. The applications of metabolomics in the molecular diagnostics of cancer.
Cheung PK; Ma MH; Tse HF; Yeung KF; Tsang HF; Chu MKM; Kan CM; Cho WCS; Ng LBW; Chan LWC; Wong SCC
Expert Rev Mol Diagn; 2019 Sep; 19(9):785-793. PubMed ID: 31414918
[No Abstract] [Full Text] [Related]
9. Omics approaches for the assessment of biological responses to nanoparticles.
Abdelkader Y; Perez-Davalos L; LeDuc R; Zahedi RP; Labouta HI
Adv Drug Deliv Rev; 2023 Sep; 200():114992. PubMed ID: 37414362
[TBL] [Abstract][Full Text] [Related]
10. Myeloid transformation of plasma cell myeloma: molecular evidence of clonal evolution revealed by next generation sequencing.
Gralewski JH; Post GR; van Rhee F; Yuan Y
Diagn Pathol; 2018 Feb; 13(1):15. PubMed ID: 29463311
[TBL] [Abstract][Full Text] [Related]
11. Pathobiology and Diagnosis of Multiple Myeloma.
Brigle K; Rogers B
Semin Oncol Nurs; 2017 Aug; 33(3):225-236. PubMed ID: 28688533
[TBL] [Abstract][Full Text] [Related]
12. Predicting the impact of combined therapies on myeloma cell growth using a hybrid multi-scale agent-based model.
Ji Z; Su J; Wu D; Peng H; Zhao W; Nlong Zhao B; Zhou X
Oncotarget; 2017 Jan; 8(5):7647-7665. PubMed ID: 28032590
[TBL] [Abstract][Full Text] [Related]
13. "Omics" in pharmaceutical research: overview, applications, challenges, and future perspectives.
Yan SK; Liu RH; Jin HZ; Liu XR; Ye J; Shan L; Zhang WD
Chin J Nat Med; 2015 Jan; 13(1):3-21. PubMed ID: 25660284
[TBL] [Abstract][Full Text] [Related]
14. CHO-Omics Review: The Impact of Current and Emerging Technologies on Chinese Hamster Ovary Based Bioproduction.
Stolfa G; Smonskey MT; Boniface R; Hachmann AB; Gulde P; Joshi AD; Pierce AP; Jacobia SJ; Campbell A
Biotechnol J; 2018 Mar; 13(3):e1700227. PubMed ID: 29072373
[TBL] [Abstract][Full Text] [Related]
15. Multiomics Data Triangulation for Asthma Candidate Biomarkers and Precision Medicine.
Pecak M; Korošec P; Kunej T
OMICS; 2018 Jun; 22(6):392-409. PubMed ID: 29927718
[TBL] [Abstract][Full Text] [Related]
16. Current Understanding of the Potential of Proteomics and Metabolomics Approaches in Cancer Chemoresistance: A Focus on Multiple Myeloma.
Chanukuppa V; Taware R; Chatterjee T; Sharma S; More TH; Taunk K; Kumar S; Santra MK; Rapole S
Curr Top Med Chem; 2018; 18(30):2584-2598. PubMed ID: 30499398
[TBL] [Abstract][Full Text] [Related]
17. From Genomics to Omics Landscapes of Parkinson's Disease: Revealing the Molecular Mechanisms.
Redenšek S; Dolžan V; Kunej T
OMICS; 2018 Jan; 22(1):1-16. PubMed ID: 29356624
[TBL] [Abstract][Full Text] [Related]
18. Proteomics: addressing the challenges of multiple myeloma.
Ge F; Tao S; Bi L; Zhang Z; Zhang X
Acta Biochim Biophys Sin (Shanghai); 2011 Feb; 43(2):89-95. PubMed ID: 21212069
[TBL] [Abstract][Full Text] [Related]
19. Overcoming multiple myeloma drug resistance in the era of cancer 'omics'.
Guang MHZ; McCann A; Bianchi G; Zhang L; Dowling P; Bazou D; O'Gorman P; Anderson KC
Leuk Lymphoma; 2018 Mar; 59(3):542-561. PubMed ID: 28610537
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of Syndecan-1 in the bone marrow microenvironment in multiple myeloma is associated with angiogenesis.
Andersen NF; Kristensen IB; Preiss BS; Christensen JH; Abildgaard N
Eur J Haematol; 2015 Sep; 95(3):211-7. PubMed ID: 25353275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
